99mtc glucarate high-resolution imaging of drug sensitive and drug resistant human breast cancer xenografts in scid mice

Nuclear Medicine Communications

Volumn 25, Issue 7, 2004, Pages 711-720

  Liu, Zhonglin ^a   Stevenson, Gail D ^a   Barrett, Harrison H ^a   Kastis, George A ^a   Bettan, Michel ^a   Furenlid, Lars R ^a   Wilson, Donald W ^a   Woolfenden, James M ^a   Pak, Koon Yan ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

99mTc glucarate; 99mTc sestamibi; Breast cancer; High resolution SPECT; Multidrug resistant; SCID mice

Indexed keywords

DIAGNOSTIC AGENT; DOXORUBICIN; DRUG DERIVATIVE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; SACCHARIC ACID; TECHNETIUM COMPLEX; TECHNETIUM TC 99M GLUCARATE; TECHNETIUM 99M;

ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BREAST TUMOR; COMPARATIVE STUDY; DRUG RESISTANCE; EVALUATION; FEASIBILITY STUDY; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; MOUSE; MOUSE MUTANT; MULTIDRUG RESISTANCE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION; TUMOR CELL LINE; VALIDATION STUDY; XENOGRAFT; ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; BIOACCUMULATION; BREAST CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DATA ANALYSIS; DRUG DETERMINATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IMAGING SYSTEM; INJECTION; NONHUMAN; STATISTICAL SIGNIFICANCE; THIGH; WESTERN BLOTTING;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEASIBILITY STUDIES; GLUCARIC ACID; METABOLIC CLEARANCE RATE; MICE; MICE, SCID; ORGAN SPECIFICITY; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TRANSPLANTATION, HETEROLOGOUS;

EID: 3142583367     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/01.mnm.0000130243.06821.90     Document Type: Article

References (35)

1. Maublant J. Scintigraphic imaging of breast tumors. Eur J Radiology 1997; 24:2-10.
2. Buscombe JR, Cwikla JB, Thakrar DS, Hilson AJ. Scintigraphic imaging of breast cancer: a review. Nucl Med Commun 1997; 18:698-709.
3. 99mTc-sestamibi breast imaging: multicenter trial results. J Nucl Med 2000; 41:1973-1979.
4. Bennink RJ, Rijks LJ, van Tienhoven G, Noorduyn LA, Janssen AG, Sloof GW. Estrogen receptor status in primary breast cancer: iodine 123-labeled cis-11beta-methoxy-17alpha-iodovinyl estradiol scintigraphy. Radiology 2001; 220:774-779.
5. Ivancevic V, Wolter A, Winzer K, Aldinger H, Muller JM, Munz DL. Intraindividual comparison of F-18-fluorodeoxyglucose and Tc-99m-tetrofosmin in planar scintimammography and SPECT. Clin Positron Imaging 2000; 3:17-29.
6. Berghammer P, Obwegeser R, Mulauer-Ertl S, Karanikas G, Wiltschke C, Kubista E, et al. 99m-Tc-tetrofosmin scintigraphy and breast cancer. Gynecol Oncol 1999; 73:87-90.
7. m-glucarate. Nucl Med Commun 1997; 18:241-251.
8. 99mTc-D-glucaric acid in patients with breast cancer [Abstract]. J Nucl Med 2002; 43(suppl):288p.
9. Khalkhali I, Baum JK, Villanueva-Meyer J, Edell SL, Hanelin LG, Lugo CE, et al. (99m)Tc sestamibi breast imaging for the examination of patients with dense and fatty breasts: multicenter study. Radiology 2002; 222:149-155.
10. Jackson VP, Henrick RE, Feig SA, Kopans DB. Imaging of the radiographically dense breast. Radiology 1993; 188:297-301.
11. Krishnaiah G, Sher-Ahmed A, Ugwu-Dike M, Regan P, Singer J, Totoonchie A, et al. Technetium-99m sestamibi scintimammography complements mammography in the detection of breast cancer. Breast J 2003; 9:288-294.
12. Alonso O, Massardo T, Delgado LB, Horvath J, Kabasakal L, Llamas-Olier A, et al. Is (99m)Tc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses? J Nucl Med 2001; 42:1614-1621.
13. Riordan JR, Deuchars K, Kartner N, Alon N, Trent J, Ling V. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature 1983; 316:817-819.
14. Hamada H, Tsuruo I. Functional role for the 170- to 180-kDa glycoprotein specific to drug-resistant tumor cells as revealed by monoclonal antibodies. Proc Natl Acad Sci USA 1986; 83:7785-7789.
15. Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res 1993; 53:977-984.
16. Rao VV, Chiu ML, Kronauge JF, Piwnica-Worms D. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi. J Nucl Med 1994; 35:510-515.
17. Del Vecchio S, Ciarmiello A, Pace L, Potena MI, Carriero MV, Mainolfi C, et al. Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients. J Nucl Med 1997; 38:1348-1351.
18. Columbi A, Maroni M, Antonini C, Fait A, Zocchetti C, Foà V. Influence of sex, age and smoking habits on urinary excretion of D-glucaric acid. Clin Chim Acta 1983; 128:349-358.
19. 99mTc glucaric acid. J Nucl Med 1991; 32:263-268.
20. Yaoita H, Uehara T, Brownell AL, Rabito CA, Ahmad M, Khaw BA, et al. Localization of technetium-99m-glucarate in zones of acute cerebral injury. J Nucl Med 1991; 32:272-278.
21. 99mTc-labeled glucarate. Circulation 1997; 95:1577-1584.
22. 99mTc-D-glucaric acid in humans. In: (editor). Clinical Medicine and Research XXII. Basel, Switzerland: Birkhaüser Verlag; 1997, pp. 359-364.
23. Taylor CW, Dalton WS, Parrish PR, Gleason MC, Bellamy WT, Thompson FH. Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Br J Cancer 1991; 63:923-929.
24. Klein WP, Barrett HH, Pang IW, Patton DD, Rogulski MM, Sain JD, et al. FASTSPECT: Electrical and mechanical design of a high-resolution dynamic SPECT imager. Conference Record of the 1995 IEEE Nuclear Science Symposium and Medical Imaging, San Francisco, CA 1995; 2:931-933.
25. Kastis GK, Barber HB, Barrett HH, Giggord HC, Pang IW, Patton DD, et al. High resolution SPECT imager for three-dimensional imaging of small animals [Abstract]. J Nucl Med 1998; 39(suppl):9P.
26. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50:2198-2202.
27. Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile) technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990; 31:1646-1653.
28. Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, Piwnica-Worms D. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33:1516-1522.
29. Piwnica-Worms D, Kronauge JF, Delmon L, Holman BL, Marsh JD, Jones AG. Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells. J Nucl Med 1990; 31:464-472.
30. ten Kate CI, Fishman AJ, Wilkinson RA. Tc-99m-glucaric acid: A glucose analogue [Abstract]. Eur J Nucl Med 1990; 17:451.
31. Webb TE, Pham-Nguyen MH, Darby M, Hamme AT. Pharmacokinetics relevant to the anti-carcinogenic and anti-tumor activities of glucarate and the synergistic combination of glucarate:retinoid in the rat. Biochem Pharmacol 1994; 47:1655-1660.
32. Abou-Issa H, Dwivedi C, Curley RW, Kirkpatrick R, Koolemans-Beynen A, Engineer FN, et al. Basis for the anti-tumor and chemopreventive activities of glucarate and the glucarate:retinoid combination. Anticancer Res 1993; 13:395-399.
33. Maurer AH, Caroline DF, Jadali FJ, Manzone TA, Maier WP, Au FC, et al. Limitations of craniocaudal thallium-201 and technetium-99m-sestamibi mammoscintigraphy. J Nucl Med 1995; 36:1696-1700.
34. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H, et al. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up. J Nucl Med 1995; 36:1784-1789.
35. Yutani K, Shiba E, Kusuoka H, Tatsumi M, Uehara T, Taguchi T, et al. Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis. J Comput Assist Tomogr 2000; 24:274-280.